| Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes M Mogensen, K Sahlin, M Fernstrom, D Glintborg, BF Vind, ... Diabetes 56 (6), 1592-1599, 2007 | 691 | 2007 |
| An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome D Glintborg, M Andersen Gynecological endocrinology 26 (4), 281-296, 2010 | 264 | 2010 |
| Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome KH Rubin, D Glintborg, M Nybo, B Abrahamsen, M Andersen The Journal of Clinical Endocrinology & Metabolism 102 (10), 3848-3857, 2017 | 234 | 2017 |
| Reduced expression of nuclear-encoded genes involved in mitochondrial oxidative metabolism in skeletal muscle of insulin-resistant women with polycystic ovary syndrome V Skov, D Glintborg, S Knudsen, T Jensen, TA Kruse, Q Tan, K Brusgaard, ... Diabetes 56 (9), 2349-2355, 2007 | 227 | 2007 |
| Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome D Glintborg, KH Rubin, M Nybo, B Abrahamsen, M Andersen Cardiovascular diabetology 17, 1-12, 2018 | 223 | 2018 |
| Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls D Glintborg, M Andersen, C Hagen, J Frystyk, V Hulstrøm, A Flyvbjerg, ... European journal of endocrinology 155 (2), 337-345, 2006 | 183 | 2006 |
| Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome D Glintborg, K Hass Rubin, M Nybo, B Abrahamsen, M Andersen European journal of endocrinology 172 (5), 627-638, 2015 | 172 | 2015 |
| Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial D Glintborg, M Andersen, C Hagen, L Heickendorff, AP Hermann The Journal of Clinical Endocrinology & Metabolism 93 (5), 1696-1701, 2008 | 165 | 2008 |
| Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment K Højlund, D Glintborg, NR Andersen, JB Birk, JT Treebak, C Frøsig, ... Diabetes 57 (2), 357-366, 2008 | 162 | 2008 |
| Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis D Glintborg, JE Henriksen, M Andersen, C Hagen, J Hangaard, ... Fertility and sterility 82 (6), 1570-1579, 2004 | 155 | 2004 |
| Normo-and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life P Pinola, K Puukka, TT Piltonen, J Puurunen, E Vanky, ... Fertility and sterility 107 (3), 788-795. e2, 2017 | 127 | 2017 |
| Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis AK Pagsberg, S Tarp, D Glintborg, AD Stenstrøm, A Fink-Jensen, ... Journal of the American Academy of Child & Adolescent Psychiatry 56 (3), 191-202, 2017 | 127 | 2017 |
| The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective A Pottegård, BK Bjerregaard, D Glintborg, J Hallas, SI Moreno European journal of clinical pharmacology 68, 1443-1450, 2012 | 125 | 2012 |
| Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment D Glintborg, K Højlund, M Andersen, JE Henriksen, H Beck-Nielsen, ... Diabetes care 31 (2), 328-334, 2008 | 109 | 2008 |
| Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in … D Glintborg, ML Altinok, H Mumm, AP Hermann, P Ravn, M Andersen The Journal of Clinical Endocrinology & Metabolism 99 (7), 2584-2591, 2014 | 108 | 2014 |
| Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men D Glintborg, LL Christensen, T Kvorning, R Larsen, K Brixen, ... Mediators of inflammation 2013 (1), 539156, 2013 | 103 | 2013 |
| Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with … D Glintborg, M Andersen, B Richelsen, JM Bruun Clinical endocrinology 71 (5), 652-658, 2009 | 103 | 2009 |
| A 12‐month randomized crossover study on the effects of lanreotide Autogel and octreotide long‐acting repeatable on GH and IGF‐l in patients with acromegaly M Andries, D Glintborg, A Kvistborg, C Hagen, M Andersen Clinical Endocrinology 68 (3), 473-480, 2008 | 102 | 2008 |
| Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome V Skov, D Glintborg, S Knudsen, Q Tan, T Jensen, TA Kruse, ... PloS one 3 (6), e2466, 2008 | 97 | 2008 |
| Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark D Glintborg, H Mumm, D Hougaard, P Ravn, M Andersen Clinical endocrinology 73 (6), 732-738, 2010 | 95 | 2010 |
Katrine Hass RubinHead of Research and associate professor OPEN, SDUVerified email at health.sdu.dk
